Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Cavernous Malformation, CerebralCavernous AngiomaCavernous HemangiomaCavernous Hemangioma of BrainSeizuresSeizures, EpilepticEpilepsy

Trial Locations (2)

RECRUITING

Beijing Tiantan Hospital, Capital Medical University, Beijing

RECRUITING

Peking University International Hospital, Beijing

All Listed Sponsors

collaborator

Peking University International Hospital

OTHER

lead

yuanli Zhao

OTHER